biomers.net
Private Company
Funding information not available
Overview
biomers.net is a well-established, private German contract research organization (CRO) specializing in custom oligonucleotide synthesis and modification. With over two decades of operation, it has built a robust technology platform capable of producing a wide range of oligos, from simple PCR primers to complex probes and conjugates for qPCR, FISH, antisense, and diagnostic assays, including for COVID-19. The company follows a business-to-business (B2B) service model, catering primarily to academic, biotech, and diagnostic clients worldwide, with a strong emphasis on technical support and rapid turnaround. Its financial position appears stable as a revenue-generating entity, though specific figures are not disclosed.
Technology Platform
Custom oligonucleotide synthesis and chemical modification platform for DNA, RNA, PNA, and LNA, specializing in a wide array of conjugations, labels, and backbone modifications for research, diagnostic, and therapeutic applications.
Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded oligo synthesis market dominated by large multinationals (Integrated DNA Technologies, Thermo Fisher Scientific) and numerous other specialized CROs. biomers.net differentiates through deep expertise in complex chemical modifications, a broad modification catalog, and a focus on customer service and technical support for European and international clients.